{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:49:27Z","timestamp":1740152967485,"version":"3.37.3"},"reference-count":41,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2017,4,3]]},"DOI":"10.1080\/13696998.2016.1271336","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T02:21:53Z","timestamp":1482114113000},"page":"371-381","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis"],"prefix":"10.1080","volume":"20","author":[{"given":"Guangying","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohui","family":"Dong","sequence":"additional","affiliation":[{"name":"Institute for Social Security Research, Ministry of Human Resources and Social Security of P.R.C, Beijing, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, the First Affiliated Hospital of Soochow University, Suzhou, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng Chuen","family":"Tan","sequence":"additional","affiliation":[{"name":"Health Economics & Outcomes Research, IMS Health Asia Pacific, Singapore;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"Novartis Oncology (China), Beijing, PR China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengbin","family":"Xiong","sequence":"additional","affiliation":[{"name":"Health Economics & Outcomes Research, IMS Health China, Shanghai, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"CIT0001","first-page":"721","volume":"30","author":"Wang JX","year":"2009","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"CIT0002","first-page":"3","volume":"2","author":"He QT","year":"1993","journal-title":"Inner Mongolia Med J"},{"key":"CIT0003","first-page":"114","volume":"18","author":"Hu JL","year":"2004","journal-title":"Chin Med J Commun"},{"journal-title":"Zhonghua Xue Ye Xue Za Zhi","year":"1994","author":"Tang ZX","key":"CIT0004"},{"key":"CIT0005","first-page":"347","volume":"22","author":"Zhang XY","year":"2001","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.245"},{"volume-title":"Chronic myelogenous leukemia","year":"2003","author":"Bian S.","key":"CIT0007"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1188\/05.CJON.535-538"},{"volume-title":"Leukemia \u2013 Chronic Myeloid (Myelogenous)","year":"2008","author":"American Cancer Society.","key":"CIT0009"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Hughes TP, Ross DM, Melo JV. Management of patients with chronic myeloid leukemia. Handbook of chronic myeloid leukemia. Switzerland: Springer International Publishing, 2014. pp. 35-51","DOI":"10.1007\/978-3-319-08350-6_4"},{"issue":"3","key":"CIT0011","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1111\/j.1524-4733.2009.00635.x","volume":"12","author":"Chen Z","year":"2009","journal-title":"Value Health"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273979"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.159"},{"key":"CIT0014","first-page":"633","volume":"37","author":"Chinese Society of Hematology CMA","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.06.006"},{"key":"CIT0016","unstructured":"Novartis. Oncology Patient Assistance Programs. Novartis Global. https:\/\/www.novartis.com\/about-us\/corporate-responsibility\/access-healthcare\/global-access-programs\/oncology-patient. Accessedon 29 Sep 2016"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20694"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2010.495132"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"A458","DOI":"10.1016\/j.jval.2015.09.1177","volume":"18","author":"Shin M","year":"2015","journal-title":"Value Health"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00663.x"},{"key":"CIT0021","unstructured":"Introduction. The First Affiliated Hospital of Soochow University Suzhou First People's Hospital. Suzhou, China. http:\/\/fyy.sdfyy.cn\/Main\/Display_B721_A0.html. Accessed on 29 Sep 2016."},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-601674"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V82.2.398.398","volume":"82","author":"Hehlmann R","year":"1993","journal-title":"Blood"},{"volume-title":"Health: investing in health for economic development. Report of the Commission on Macroeconomics and Health","year":"2001","author":"WHO. WHO Macroeconomics","key":"CIT0024"},{"key":"CIT0025","unstructured":"NBS. GDP per capita in China. National Bureau of Statistics of China. Beijing. 2015. http:\/\/data.stats.gov.cn\/easyquery.htm?cn=C01 Accessed on 29 Sep 2016"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002315"},{"key":"CIT0028","first-page":"803","volume":"52","author":"Jiang Q","year":"2013","journal-title":"Chin J Intern Med"},{"key":"CIT0029","unstructured":"American Cancer Society. Stem cell transplant for chronic myeloid leukemia. http:\/\/www.cancer.org\/cancer\/leukemia-chronicmyeloidcml\/detailedguide\/leukemia-chronic-myeloid-myelogenous-treating-bone-marrow-stem-cell. Accessed on 29 Sep 2016"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.12.154"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523050-00010"},{"key":"CIT0032","unstructured":"NICE. National Institute for Health and Care Excellence. Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia. Technology appraisal guidance. London. 2012. http:\/\/www.nice.org.uk\/guidance\/ta251 Accessed on 29 Sep 2016"},{"key":"CIT0033","unstructured":"NICE. Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance (TA241). London. 2012. http:\/\/www.nice.org.uk\/guidance\/ta241 Accessed on 29 Sep 2016."},{"key":"CIT0034","unstructured":"NCCN. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Chronic Myeloid Leukemia. London. 2009. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/cml.pdf Accessed on 29 Sep 2016"},{"key":"CIT0035","first-page":"3035","volume":"93","author":"Gao GL","year":"2013","journal-title":"Natl Med J China"},{"key":"CIT0036","first-page":"23","volume":"23","author":"Jin H","year":"2015","journal-title":"Chin J Trauma Disabil Med"},{"key":"CIT0037","first-page":"563","volume":"38","author":"Meng Y","year":"2012","journal-title":"J Jilin Uni (Med Ed)"},{"key":"CIT0038","first-page":"430","volume":"5","author":"Wu RJ","year":"2014","journal-title":"Chin J Convalesc Med"},{"key":"CIT0039","first-page":"156","volume":"13","author":"Yang DD","year":"2015","journal-title":"Contemp Med Forum"},{"key":"CIT0040","first-page":"126","volume":"35","author":"Zhou M","year":"2014","journal-title":"Chin J Hematol"},{"key":"CIT0041","first-page":"1660","volume":"28","author":"Zou WY","year":"2008","journal-title":"J Southern Med Uni"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2016.1271336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T23:57:39Z","timestamp":1599436659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2016.1271336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,3]]}},"alternative-id":["10.1080\/13696998.2016.1271336"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2016.1271336","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"type":"print","value":"1369-6998"},{"type":"electronic","value":"1941-837X"}],"subject":[],"published":{"date-parts":[[2017,1,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-11-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}